Late stent thrombosis--the "vulnerable" stent.

Suppr

超能文献

作者信息

Waksman Ron

出版信息

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):54-6. doi: 10.1002/ccd.21276.

DOI:10.1002/ccd.21276

PMID:17585385

Abstract

摘要

相似文献

Late stent thrombosis--the "vulnerable" stent.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):54-6. doi: 10.1002/ccd.21276.

Recurrent very late stent thrombosis after bare-metal stent implantation.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):51-3. doi: 10.1002/ccd.21044.

Are we totally clear?

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):987-8. doi: 10.1002/ccd.22335.

Stent thrombosis in the era of drug eluting stents.

Minerva Cardioangiol. 2007 Apr;55(2):199-211.

The long-term results of the "Endeavor" stent.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):996-9. doi: 10.1002/ccd.22334.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):24-8. doi: 10.1016/j.carrev.2007.06.002.

Off-label use and the spectre of drug-eluting stent thrombosis.

Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.

SES for AMI: moving in the right direction.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):333-4. doi: 10.1002/ccd.22185.

Drug-eluting stent in saphenous vein graft lesions.

Catheter Cardiovasc Interv. 2008 Jun 1;71(7):894-5. doi: 10.1002/ccd.21615.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017.

引用本文的文献

Undesired Outcomes of the Catania Stent Compared to the Xience Stent in Patients Undergoing Angioplasty: A Double-Blind Randomized Controlled Trial.

Adv Biomed Res. 2017 Nov 30;6:154. doi: 10.4103/2277-9175.219419. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Late stent thrombosis--the "vulnerable" stent.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):54-6. doi: 10.1002/ccd.21276.

Recurrent very late stent thrombosis after bare-metal stent implantation.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):51-3. doi: 10.1002/ccd.21044.

Are we totally clear?

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):987-8. doi: 10.1002/ccd.22335.

Stent thrombosis in the era of drug eluting stents.

Minerva Cardioangiol. 2007 Apr;55(2):199-211.

The long-term results of the "Endeavor" stent.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):996-9. doi: 10.1002/ccd.22334.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):24-8. doi: 10.1016/j.carrev.2007.06.002.

Off-label use and the spectre of drug-eluting stent thrombosis.

Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.

SES for AMI: moving in the right direction.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):333-4. doi: 10.1002/ccd.22185.

Drug-eluting stent in saphenous vein graft lesions.

Catheter Cardiovasc Interv. 2008 Jun 1;71(7):894-5. doi: 10.1002/ccd.21615.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017.

引用本文的文献

Undesired Outcomes of the Catania Stent Compared to the Xience Stent in Patients Undergoing Angioplasty: A Double-Blind Randomized Controlled Trial.

Adv Biomed Res. 2017 Nov 30;6:154. doi: 10.4103/2277-9175.219419. eCollection 2017.